The role of P2X4 receptors in chronic pain: A potential pharmacological target
Open Access
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 129, 110447
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81760418)
- National Natural Science Foundation of China (8156100154)
- National Natural Science Foundation of China (81260190)
This publication has 136 references indexed in Scilit:
- P2X4 receptors and neuropathic painFrontiers in Cellular Neuroscience, 2013
- Tightening of the ATP‐binding sites induces the opening of P2X receptor channelsThe EMBO Journal, 2012
- Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain developmentThe EMBO Journal, 2011
- Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors within vivoefficacy in a pain modelBritish Journal of Pharmacology, 2011
- P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimersBritish Journal of Pharmacology, 2011
- The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptorsPurinergic Signalling, 2011
- P2X4 receptors mediate PGE2 release by tissue‐resident macrophages and initiate inflammatory painThe EMBO Journal, 2010
- Analysis of Assembly and Trafficking of Native P2X4 and P2X7 Receptor Complexes in Rodent Immune CellsJournal of Biological Chemistry, 2009
- P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase ActivationThe Journal of Neuroscience, 2009
- Cloning and Tissue Distribution of a Novel P2X Receptor from Rat BrainBiochemical and Biophysical Research Communications, 1996